Kathleen Clare Toomey MD

Cancer and Blood Disorders Physician

30 Rehill AveSte 2500Somerville, NJ 08876
Phone+1 908-927-8702
Fax+1 908-927-8949

Dr. Toomey is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Toomey's full profile Already have an account?

Summary

Dr. Kathleen Toomey, based in Somerville, NJ, specializes in Oncology with a focus on hematology and medical oncology. She completed her residency in Internal Medicine at Saint Peter's University Hospital/Rutgers Robert Wood Johnson Medical School in 1982 and her fellowship in Hematology and Medical Oncology in 1985 at Rutgers Health/Robert Wood Johnson Medical School. Dr. Toomey is currently practicing at Steeplechase Cancer Center and previously partnered with Regional Cancer Care Associates. She has several publications related to multiple myeloma, with recent works featured in Clinical Lymphoma, Myeloma & Leukemia and other journals. Her clinical trial involvements focus on breast cancer and multiple myeloma treatments. She has been recognized in multiple publications as a top doctor in the New York Metro Area and for women's health and cancer care.

Education & Training

Rutgers Health/Robert Wood Johnson Medical SchoolFellowship, Hematology and Medical Oncology, 1982 - 1985
Saint Peter's University Hospital/Rutgers Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 1979 - 1982
University of BolognaClass of 1978

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NJ State Medical License 1980 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

New York Magazine: Top Doctors
Inside Jersey Magazine, Top Doctors for Women's Health
Top Doctors: New York Metro Area

Clinical Trials

S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo
COMPLETED
PHASE3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Feb 28
ACTIVE_NOT_RECRUITING
PHASE3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Feb 08
COMPLETED
PHASE3

Publications & Presentations

PubMed

2 citations
Characteristics and Treatment Patterns of Long-surviving Patients With Multiple Myeloma: Over 13 Years of Follow-up in the ConnectMM Registry.
Howard R Terebelo, James Omel, Lynne I Wagner, James W Hardin, Robert M Rifkin
Clinical Lymphoma, Myeloma & Leukemia. 2025-01-01
2 citations
Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry.
Sikander Ailawadhi, Hans C Lee, James Omel, Kathleen Toomey, James W Hardin
Blood Cancer Journal. 2024-11-11
1 citations
The Effect of Age and Other Patient Characteristics on Outcomes Among Nontransplanted Patients Who Were Treated With First-Line Lenalidomide, Bortezomib, and Dexametha...
Rafat Abonour, Hans C Lee, Robert Rifkin, Sikander Ailawadhi, James Omel
Clinical Lymphoma, Myeloma & Leukemia. 2024-10-01

Abstracts/Posters

Treatment Patterns and Outcomes in Elderly Patients with Newly Diagnosed Multiple Myeloma: Results from the Connect¬ MM Registry
Kathleen Toomey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Clinical Outcomes and Health-Related Quality of Life (HRQoL) Among Randomized Clinical Trial (RCT)-Eligible and RCT-Ineligible Patients: Results from the Connect¬ MM R...
Kathleen Toomey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
A Phase 1/2 Study to Assess Safety and Dose of Ixazomib in Combination with Cyclophosphamide and Dexamethasone in Newly Diagnosed Patients with Light Chain (AL) Amyloi...
Kathleen Toomey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

Robert Wood Johnson University Hospital Somerset Expands Breast Cancer ServicesMarch 17th, 2025
Mountainside Medical Center Recognized for Antimicrobial StewardshipMarch 16th, 2023
Steeplechase Cancer Center Somerset Expands Medical Oncology ServicesMarch 16th, 2023